COVID-19 Update: We are currently shipping orders daily. However, due to transit disruptions in some geographies, deliveries may be delayed. To provide all customers with timely access to content, we are offering 50% off our Print & eBook bundle option. Terms & conditions.
Delivery of Drugs - 1st Edition - ISBN: 9780128177761, 9780128177778

Delivery of Drugs

1st Edition

Volume 2: Expectations and Realities of Multifunctional Drug Delivery Systems

0.0 star rating Write a review
Editor: Ranjita Shegokar
Paperback ISBN: 9780128177761
eBook ISBN: 9780128177778
Imprint: Elsevier
Published Date: 4th February 2020
Page Count: 242
Sales tax will be calculated at check-out Price includes VAT/GST
279.94
200.00
170.00
143.00
125.00
Unavailable
Price includes VAT/GST

Institutional Subscription

Secure Checkout

Personal information is secured with SSL technology.

Free Shipping

Free global shipping
No minimum order.

Description

Delivery of Drugs: Expectations and Realities of Multifunctional Drug Delivery Systems, Volume Two examines the formulation of micro-nanosized drug delivery systems and recaps opportunities for using physical methods to improve efficacy via mechano-, electroporation. The book highlights innovative delivery methods like PIPAC, including discussions on the regulatory aspects of complex injectables. Written by a diverse range of international researchers from industry and academia, the chapters examine specific aspects of characterization and manufacturing for pharmaceutical applications as well as regulatory and policy aspects.

This book connects formulation scientists, regulatory experts, engineers, clinical experts and regulatory stakeholders. This level of discussion makes it a valuable reference resource for researchers in both academia and the pharmaceutical industry who want to learn more about the status of drug delivery systems.

Key Features

Delivery of Drugs examines the fabrication, optimization, scale-up, biological aspects, regulatory and clinical success of various micro and nano drug delivery systems. The volume covers site and organ specific targeting approaches, technologies used in preparation of micro - nanoparticles, challenges of complex type of drug delivery forms and role of physical methods in achieving targeted drug effect. Written by a diverse range of international researchers the chapters examine the specific aspects of characterization and manufacturing of drug delivery system for pharmaceutical application and its regulatory aspects.

The series Expectations and Realities of Multifunctional Drug Delivery Systems examines the fabrication, optimization, biological aspects, regulatory and clinical success of wide range of drug delivery carriers. This series reviews multifunctionality and applications of drug delivery systems, industrial trends, regulatory challenges and in vivo success stories. Throughout the volumes discussions on diverse aspects of drug delivery carriers, such as clinical, engineering, and regulatory, facilitate insight sharing across expertise area and form a link for collaborations between industry-academic scientists and clinical researchers.

Expectations and Realities of Multifunctional Drug Delivery Systems connects formulation scientists, regulatory experts, engineers, clinical experts and regulatory stake holders. The wide scope of the book ensures it as a valuable reference resource for researchers in both academia and the pharmaceutical industry who want to learn more about drug delivery systems.

Readership

Pharmaceutical Scientists in academia and industry; pharmacologists; regulatory experts; bioengineers

Table of Contents

  1. Polymer lipid hybrid (PLH) formulations: a synergistic approach to oral delivery of challenging therapeutics
    PAUL JOYCE, HAYLEY B. SCHULTZ, TAHLIA R. MEOLA, AND CLIVE A. PRESTIDGE
    2. Dendrimers for pharmaceutical applicationsdpotential and challenges
    JØRN B. CHRISTENSEN
    3. Electrospun nanofibers for biomedical applications
    FRANCIS KAMAU MWIIRI AND ROLF DANIELS
    4. Nanocarriers for topical delivery in psoriasis
    GAUTAM SINGHVI, SIDDHANTH HEJMADY, VAMSHI KRISHNA RAPALLI, SUNIL KUMAR DUBEY, AND  SACHIN DUBEY
    5. Mitochondria-targeted drug delivery in neurodegenerative diseases
    SARAVANA BABU CHIDAMBARAM, BIPUL RAY, ABID BHAT, AREHALLY MARAPPA MAHALAKSHMI,
    TULADHAR SUNANDA, PADAMATI JAGADEESWARI, MYSORE PRAKASH GOWRAV, RAMESH CHANDRA, AND  MEENA KISHORE SAKHARKAR
    6. Nano-structured microparticles for inhalation
    ALJOSCHA KOENNEKE, MARCEL POURASGHAR, AND MARC SCHNEIDER
    7. Physical approaches for drug delivery: an overview
    PALLAVI SHINDE, AMOGH KUMAR, KAVITHA, KOYEL DEY, L. MOHAN, SRABANI KAR, TARUN KUMAR BARIK, JAVAD SHARIFI-RAD, MOETO NAGAI, AND TUHIN SUBHRA SANTRA
    8. Complex injectables: development, delivery, and advancement
    ABHIJEET PANDEY, DEBJANI SINGH, NAMDEV DHAS, AKHILESH KUMAR TEWARI, KAMLA PATHAK,
    VIVEKANAND CHATAP, KAMAL SINGH RATHORE, AND SRINIVAS MUTALIK
    9. Pressurized intraperitoneal aerosol chemotherapy (PIPAC) in colorectal cancer treatment
    XAVIER DELGADILLO AND PHILIPPE WUTHRICH

Details

No. of pages:
242
Language:
English
Copyright:
© Elsevier 2020
Published:
4th February 2020
Imprint:
Elsevier
Paperback ISBN:
9780128177761
eBook ISBN:
9780128177778

About the Editor

Ranjita Shegokar

Dr. Ranjita Shegokar holds a PhD degree in Pharmaceutical Technology from the SNDT University, India, and has been postdoctoral researcher in the Department of Pharmaceutics, Biopharmaceutics and NutriCosmetics at Free University of Berlin, Germany. Since last 8 years she is working in the pharmaceutical industry in various technical/R&D roles. Currently, she serves as Director of Pharma Business Unit at Capnomed GmbH, Germany. She has authored many research articles, book chapters, and presented several research papers in conferences. She has filed multiple patent application in area of drug delivery and drug targeting. She received several national and international awards for her research. Her areas of interest include polymeric nanoparticles, nanocrystals, lipid nanoparticles (SLNs/NLCs), nanoemulsions and role of excipients in delivery systems.

Affiliations and Expertise

Director, Pharma Business Unit, Capnomed GmbH, Germany

Ratings and Reviews